Pulmonary, Gastrointestinal and Urogenital PharmacologyDifferences in the characteristics of tolerance to μ-opioid receptor agonists in the colon from wild type and β-arrestin2 knockout mice
Introduction
Chronic use of opioids is associated with the rapid development of tolerance. Increasing the dose to compensate for the loss in efficacy raises the risk of adverse events including overdose, withdrawal and dependence. The extent of tolerance varies significantly depending on the pharmacological effect e.g. opioid tolerance develops quicker to urinary retention and respiratory depression effects compared to the analgesic effects, whereas little manifests to constipation in humans. It is for this reason that constipation is a major side effect observed in opioid-induced bowel dysfunction (Holzer et al., 2009, Thomas, 2008).
Several mechanisms have been proposed for the development of opioid tolerance depending on the ligand and tissue preparation. Classical mechanisms include decreased cell surface receptor expression, prolonged signaling resulting in desensitization, receptor phosphorylation, etc. It is however becoming increasingly clear that functional selectivity manifests with different ligands targeting the same opioid receptor (for review, see Raehal et al., 2011). Ligands that are less efficacious at promoting desensitization and internalization such as morphine produce significant antinociceptive tolerance while high efficacy agonists including etorphine and fentanyl produce less (Pawar et al., 2007, Raehal et al., 2011, Sirohi et al., 2008). In contrast, we recently reported the lack of tolerance to morphine in the colon from mice and guinea pigs: However, tolerance developed in the colon of β-arrestin2 knockout (KO) mice following repeated administration of morphine (Kang et al., 2012). Based on these findings, we compared the effects of other opioids towards tolerance development in the mouse colon. While numerous studies have focused on the effects of various opioids on antinociceptive tolerance, to our knowledge, no studies have investigated the effects of high efficacy ligands such as etorphine on tolerance in the colon. Etorphine, DAMGO and fentanyl desensitization pathways have been observed to be dependent on β-arrestin2, an integral protein which facilitates receptor desensitization, whereas morphine and levorphanol show minimal recruitment of the moiety (McPherson et al., 2010, Whistler and von Zastrow, 1998). To delineate possible differential development of tolerance among opioid agonists, we assessed the ability of repeated opioid exposure to induce contraction of isolated ileum and colon circular muscle from C57BL/6 wild-type and β-arrestin2 KO mice. In this preparation, enhanced spontaneous contractions occur as a result of suppression of inhibitory tone by μ-opioid receptors located on nitrergic and VIP-ergic myenteric neurons (Grider and Makhlouf, 1987, Iwata et al., 2007).
Our results demonstrate lack of tolerance to repeated administration of DAMGO in the colon similar to that previously observed with morphine. Partial tolerance occurs to fentanyl while significant tolerance manifests with etorphine. However, tolerance occurs to all agonists in the β-arrestin2 KO mouse colon. The differences between highly potent agonists like fentanyl and etorphine and the less potent DAMGO and morphine, point to potential ligand biased signaling. Our data demonstrate the downregulation of β-arrestin2 to be necessary for development or enhancement of tolerance to specific agonists and further illustrate differences between CNS models where tolerance is abrogated, in contrast to the colon where it is enhanced in the absence of β-arrestin2.
Section snippets
Drugs and Chemicals
Morphine (morphine sulfate pentahydrate salt), fentanyl (as citrate salt) and DAMGO ([d-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin acetate) were procured from Sigma-Aldrich Co. (St. Louis, MO), whereas etorphine (as hydrochloride salt) was acquired from the National Institute on Drug Abuse (NIDA), Bethesda, MD and CTAP (H-d-Phe-Cys-Tyr-d-Trp-Arg-Thr-Pen-Thr-NH2) was procured from Tocris Biosciences (Ellisville, MO). Fentanyl and morphine were dissolved in water and etorphine and DAMGO were dissolved
Development of tolerance in circular muscle
Tolerance was determined by assessing the ability of repeated transient opioid exposure to induce contraction of the ileum and colon circular muscle ring preparations in vitro. The drug concentrations used (DAMGO — 3 μM, fentanyl — 0.1 μM, and etorphine — 0.01 μM) were based on preliminary in vitro concentration response studies performed to determine equipotent concentrations that produced significant quantifiable contractions from which tolerance could be assessed. Fig. 1A shows the
Discussion
In this study we compared the ability of three different opioid analgesics to induce tolerance in the ileum and colon of wild type and β-arrestin2 KO mice. While DAMGO, fentanyl and etorphine all produced tolerance upon repeated administration in the isolated ileum of WT and KO mice, there was differential development of tolerance in the colon. Similar to our previous findings with morphine (Kang et al., 2012, Ross et al., 2008), tolerance did not develop to DAMGO in the colon of the WT but was
Acknowledgments
This work was supported by NIH DA024009.
References (31)
- et al.
Opioids: cellular mechanisms of tolerance and physical dependence
Curr. Opin. Pharmacol.
(2005) - et al.
mu-Opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance
Brain Res. Mol. Brain Res.
(1998) Opioid receptors in the gastrointestinal tract
Regul. Pept.
(2009)- et al.
Morphine leads to contraction of the ileal circular muscle via inhibition of the nitrergic pathway in mice
Eur. J. Pharmacol.
(2007) - et al.
Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization
J. Biol. Chem.
(1998) - et al.
Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2
Eur. J. Pharmacol.
(2007) - et al.
Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination
J. Biol. Chem.
(2003) - et al.
The analgesic efficacy of fentanyl: relationship to tolerance and mu-opioid receptor regulation
Pharmacol. Biochem. Behav.
(2008) - et al.
PKC and PKA inhibitors reinstate morphine-induced behaviors in morphine tolerant mice
Pharmacol. Res.
(2006) Opioid-induced bowel dysfunction
J. Pain Symptom Manage.
(2008)